Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PE's Diagnostic Start-Up

This article was originally published in Start Up

Executive Summary

Less than four months after securing a broad license from Roche Molecular Systems to use PCR for clinical diagnostics, PE Corp. has hired Roche Molecular's CEO, Kathy Ordonez. PE has tasked her to build a new division within PE that will draw on technology resident in PE's Applied Biosystems Group and Celera Genomics Group, to develop, seek approval for, and market reagent and software-based standardized molecular diagnostic tests that will run on ABI's instruments.
Advertisement

Related Content

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT037081

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel